Cargando…
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
Despite effective therapies for smoking cessation, most smokers find quitting difficult and most successful quitters relapse. Considerable evidence supports a genetic risk for nicotine dependence; however, less is known about the pharmacogenetics of smoking cessation. In the first pharmacogenetic in...
Autores principales: | King, David P, Paciga, Sara, Pickering, Eve, Benowitz, Neal L, Bierut, Laura J, Conti, David V, Kaprio, Jaakko, Lerman, Caryn, Park, Peter W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260990/ https://www.ncbi.nlm.nih.gov/pubmed/22048466 http://dx.doi.org/10.1038/npp.2011.232 |
Ejemplares similares
-
A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
por: Benli, Ali Ramazan, et al.
Publicado: (2017) -
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm
por: Rose, Jed E, et al.
Publicado: (2017) -
Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials
por: Patel, Ashish R., et al.
Publicado: (2023) -
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)